Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.
Poldermans D, Boersma E, Bax JJ, Thomson IR, Paelinck B, van de Ven LL, Scheffer MG, Trocino G, Vigna C, Baars HF, van Urk H, Roelandt JR; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Poldermans D, et al. Among authors: van urk h, van de ven ll. Eur Heart J. 2001 Aug;22(15):1353-8. doi: 10.1053/euhj.2000.2555. Eur Heart J. 2001. PMID: 11465968 Clinical Trial.
Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery.
Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AF, Thomson IR, Lansberg PJ, Fleisher LA, Klein J, van Urk H, Roelandt JR, Boersma E. Poldermans D, et al. Among authors: van urk h. Circulation. 2003 Apr 15;107(14):1848-51. doi: 10.1161/01.CIR.0000066286.15621.98. Epub 2003 Apr 14. Circulation. 2003. PMID: 12695283
Optimizing long-term cardiac management after major vascular surgery: Role of beta-blocker therapy, clinical characteristics, and dobutamine stress echocardiography to optimize long-term cardiac management after major vascular surgery.
Kertai MD, Boersma E, Bax JJ, Thomson IR, Cramer MJ, van de Ven LL, Scheffer MG, Trocino G, Vigna C, Baars HF, van Urk H, Roelandt JR, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography (DECREASE) Study Group. Kertai MD, et al. Among authors: van urk h, van de ven ll. Arch Intern Med. 2003 Oct 13;163(18):2230-5. doi: 10.1001/archinte.163.18.2230. Arch Intern Med. 2003. PMID: 14557221
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
Schouten O, Poldermans D, Visser L, Kertai MD, Klein J, van Urk H, Simoons ML, van de Ven LL, Vermeulen M, Bax JJ, Lameris TW, Boersma E. Schouten O, et al. Among authors: van urk h, van de ven ll. Am Heart J. 2004 Dec;148(6):1047-52. doi: 10.1016/j.ahj.2004.05.046. Am Heart J. 2004. PMID: 15632892 No abstract available.
Fluvastatin and perioperative events in patients undergoing vascular surgery.
Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, Verhagen HJ, Khan NA, Dunkelgrun M, Bax JJ, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Schouten O, et al. Among authors: van urk h. N Engl J Med. 2009 Sep 3;361(10):980-9. doi: 10.1056/NEJMoa0808207. N Engl J Med. 2009. PMID: 19726772 Free article. Clinical Trial.
183 results